N H Greig - JoVE Visualize

Showing results (41-50 of 75) with videos related to

Pageof 8

Sort By:

Journal of Medicinal Chemistry|November 16, 2001

Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory actionQ Yu, H W Holloway, J L Flippen-Anderson, et al.

Cancer Research|April 15, 1992

Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrierY Takada, D T Vistica, N H Greig, et al.

Neuroreport|May 20, 1998

Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptorN Patel, E L Spangler, N H Greig, et al.

Endocrinology|September 21, 2001

Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agentM E Doyle, N H Greig, H W Holloway, et al.

Psychopharmacology|January 1, 1993

Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.

Neuroscience Letters|September 14, 1992

The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.

Frontiers in Molecular Biosciences|January 2, 2026

TNFα protein, DNA methylation, mRNA and miRNA expression evaluation in multiple sclerosisE Costantini, N H Greig, L Aielli, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1990

Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in ratN H Greig, T T Soncrant, H U Shetty, et al.

Alzheimer Disease and Associated Disorders|June 18, 1999

Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer diseaseS Asthana, K C Raffaele, N H Greig, et al.

Life Sciences|January 1, 1994

Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesisD K Ingram, E L Spangler, S Iijima, et al.

Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:

Pageof 8

Journal of Medicinal Chemistry|November 16, 2001

Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory actionQ Yu, H W Holloway, J L Flippen-Anderson, et al.

Cancer Research|April 15, 1992

Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrierY Takada, D T Vistica, N H Greig, et al.

Neuroreport|May 20, 1998

Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptorN Patel, E L Spangler, N H Greig, et al.

Endocrinology|September 21, 2001

Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agentM E Doyle, N H Greig, H W Holloway, et al.

Psychopharmacology|January 1, 1993

Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.

Neuroscience Letters|September 14, 1992

The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.

Frontiers in Molecular Biosciences|January 2, 2026

TNFα protein, DNA methylation, mRNA and miRNA expression evaluation in multiple sclerosisE Costantini, N H Greig, L Aielli, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1990

Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in ratN H Greig, T T Soncrant, H U Shetty, et al.

Alzheimer Disease and Associated Disorders|June 18, 1999

Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer diseaseS Asthana, K C Raffaele, N H Greig, et al.

Life Sciences|January 1, 1994

Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesisD K Ingram, E L Spangler, S Iijima, et al.

Pageof 8